Literature DB >> 10797471

Regulation of nitric oxide synthesis in the liver.

P Muriel1.   

Abstract

Nitric oxide signalling during the past two decades has been one of the most rapidly growing areas in biology. This simple free radical gas can regulate an ever-growing list of biological processes. Here the regulation of NO synthesis in the liver is reviewed. The biogenesis of nitric oxide (NO) is catalysed by nitric oxide synthases (NOS). These enzymes catalyse the oxidation of one of the guanidino nitrogens of l-arginine by molecular oxygen to form NO and citrulline. Three NOS have been identified: two constitutive (cNOS: type 1 or neuronal and type 3 or endothelial) and one inducible (iNOS: type 2). As to the liver, cNOS activity is normally detectable in Kupffer cells, whereas no cNOS is ever encoded in hepatocytes. However, hepatocytes, Kupffer and stellate cells (the three main types of liver cells) are prompted to express an intense iNOS activity once exposed to effective stimuli such as bacterial lipopolysaccharide and cytokines. This review is focused mainly on two aspects: regulation of NOS activity and expression by endogenous and exogenous compounds. Because NO production has beneficial and detrimental effects, understanding the molecular mechanisms that govern NOS is critical to developing strategies to manipulate NO production in liver diseases. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10797471     DOI: 10.1002/(sici)1099-1263(200005/06)20:3<189::aid-jat632>3.0.co;2-8

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  6 in total

1.  Cationic peptide mR18L with lipid lowering properties inhibits LPS-induced systemic and liver inflammation in rats.

Authors:  Oleg F Sharifov; Gaurav Nayyar; Vladimir V Ternovoy; Vinod K Mishra; Silvio H Litovsky; Mayakonda N Palgunachari; David W Garber; G M Anantharamaiah; Himanshu Gupta
Journal:  Biochem Biophys Res Commun       Date:  2013-06-17       Impact factor: 3.575

2.  Consumption of pasteurized human lysozyme transgenic goats' milk alters serum metabolite profile in young pigs.

Authors:  Dottie R Brundige; Elizabeth A Maga; Kirk C Klasing; James D Murray
Journal:  Transgenic Res       Date:  2009-10-22       Impact factor: 2.788

3.  The effects of L-arginine on liver damage in experimental acute cholestasis an immunohistochemical study.

Authors:  Yucel Ozsoy; Mustafa Ozsoy; Teoman Coskun; Kaya Yavuz; Kemal Ozbilgin; Kemal Namlı; Ahmet Var; Beyhan Ozyurt
Journal:  HPB Surg       Date:  2011-06-01

4.  Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine.

Authors:  Takahiro Kishikawa; Motoyuki Otsuka; Poh Seng Tan; Motoko Ohno; Xiaochen Sun; Takeshi Yoshikawa; Chikako Shibata; Akemi Takata; Kentaro Kojima; Kenji Takehana; Maki Ohishi; Sana Ota; Tomoyuki Noyama; Yuji Kondo; Masaya Sato; Tomoyoshi Soga; Yujin Hoshida; Kazuhiko Koike
Journal:  Oncotarget       Date:  2015-04-10

Review 5.  The Immunomodulatory Effects of Mesenchymal Stem Cells in Prevention or Treatment of Excessive Scars.

Authors:  Bommie Florence Seo; Sung-No Jung
Journal:  Stem Cells Int       Date:  2015-12-29       Impact factor: 5.443

6.  Delayed Liver Regeneration after Partial Hepatectomy in Aged Nos2 Knockout Mice.

Authors:  Deming Li; Jun Li; Gaiping Wang; Yanli Qin; Zhipeng Niu; Ziwei Li; Cunshuan Xu
Journal:  Cell J       Date:  2017-02-22       Impact factor: 2.479

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.